Statin Therapy Reduces Cardiovascular Risks in Seniors Aged 75 and Older Without Heightened Adverse Effects: Study
China: Real-world evidence from a target trial emulation study has shed light on the promising role of statins in the primary prevention of Cardiovascular diseases (CVDs) and all-cause mortality in old (aged 75 to 84 years) and very old (aged ≥85 years) adults.
The study published in the Annals of Internal Medicine concluded the reduction of CVD after statin therapy in patients aged 75 years or older without any evident adverse effects. Additionally, statin therapy was found to be beneficial and safe in adults aged 85 years or older.
Statins are considered potent medication for the prevention of cardiovascular events in patients who already have coronary heart disease and with little information available regarding the use of statins in older age individuals, scientists stride up to research to investigate the benefits and risks associated with the use of statins in primary prevention of (CVDs) in old (aged 75 to 84 years) and very old adults (aged ≥85 years).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.